The rare and orphan disease market exhibits a number of unique characteristics that make goal setting incredibly challenging. In this blog post, we explore one proven goal setting methodology with a track record of improving goal accuracy and equity for rare disease products.

Though large volume territories contribute so much to a biopharma company’s bottom line, many goal-based sales compensation plans actually unexpectedly penalize large volume territories. In this blog post, we explore how this inequity occurs and what you can do about it.

Accurate and equitable territory-level goals are critical to driving sales force motivation and sales. Let’s explore a three-step analysis you can conduct to examine how accurate your goals are before they’re implemented.

Let’s explore three common pitfalls in designing goal-based payout curves and how they can undermine a company’s budget.